New psoriasis pill enters final testing phase
NCT ID NCT07362017
Summary
This study aims to test the safety and effectiveness of an oral medication called ponesimod for adults with moderate-to-severe plaque psoriasis. It will involve about 300 participants who have a significant amount of their skin affected by the condition. The main goal is to see how well people tolerate the drug and if it helps control their psoriasis symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.